Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niclosamide in mild to moderate COVID-19
NCT04399356Phase 2Completed
- Sponsor
- Tufts Medical Center
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niclosamide in coronavirus disease 2019 (COVID-19), sponsored by Tufts Medical Center. Started Oct 2020; status: completed.
02
Drugs
niclosamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04399356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04399356.